LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Sk Holdings Co. Ltd.
Headquarters:
Seoul, South Korea
Website:
http://www.sk.com
Year Founded:
1987
Status:
Public
Industry Sector:
Finance
CEO:
Tae-Won Choi, PhD; Yong-Ho Jang
Number Of Employees:
4,404
Enterprise Value:
$83,373,435,192
PE Ratio:
-4.92
Exchange/Ticker 1:
KRX:034730
Exchange/Ticker 2:
N/A
Latest Market Cap:
$5,093,511,662
BioCentury
|
Mar 1, 2022
Deals
Feb. 28 Quick Takes: Heidelberg shares jump as Huadong takes stake
Plus FDA approves CTI’s pacritinib, Aurinia shares sink, Lexicon submission delayed, priority review for neoadjuvant Opdivo and more
Read More
BioCentury
|
May 8, 2017
Financial News
Aadi raises $23M series A round
Read More
BioCentury
|
Apr 29, 2013
Company News
SK Biopharmaceuticals, SK Chemicals deal
Read More
BioCentury
|
Feb 1, 2010
Clinical News
Comfyde carisbamate regulatory update
Read More
BioCentury
|
Aug 24, 2009
Clinical News
Carisbamate regulatory update
Read More
BioCentury
|
Jul 6, 2009
Finance
2H09 Milestones
Read More
BioCentury
|
May 25, 2009
Company News
Addrenex, SK Holdings deal
Read More
BioCentury
|
Dec 15, 2008
Clinical News
Comfyde carisbamate: Phase III data
Read More
BioCentury
|
Dec 15, 2008
Clinical News
Comfyde carisbamate: Phase III data
Read More
BioCentury
|
Oct 27, 2008
Clinical News
Comfyde carisbamate regulatory update
Read More
Items per page:
10
1 - 10 of 10